|
THAP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98497999999159E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.31609999999938E-05 |
| Normal-vs-Stage2 |
9.324200E-01 |
| Normal-vs-Stage3 |
4.42900000000579E-05 |
| Normal-vs-Stage4 |
2.935300E-03 |
| Stage1-vs-Stage2 |
3.501000E-01 |
| Stage1-vs-Stage3 |
2.766600E-01 |
| Stage1-vs-Stage4 |
9.490800E-01 |
| Stage2-vs-Stage3 |
2.150800E-01 |
| Stage2-vs-Stage4 |
3.551400E-01 |
| Stage3-vs-Stage4 |
5.027600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41559999994523E-06 |
| Normal-vs-AfricanAmerican |
1.004950E-01 |
| Normal-vs-Asian |
4.233500000006E-05 |
| Caucasian-vs-AfricanAmerican |
4.640400E-01 |
| Caucasian-vs-Asian |
2.219400E-01 |
| AfricanAmerican-vs-Asian |
3.171000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62049999996583E-06 |
| Normal-vs-Female |
7.540500E-02 |
| Male-vs-Female |
3.037800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.031120E-04 |
| Normal-vs-Extreme_Weight |
2.565900E-04 |
| Normal-vs-Obese |
1.123250E-01 |
| Normal-vs-Extreme_Obese |
2.045700E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.864600E-01 |
| Normal_Weight-vs-Obese |
1.539420E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.733600E-01 |
| Extreme_Weight-vs-Obese |
3.081000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.850400E-01 |
| Obese-vs-Extreme_Obese |
2.856800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.677700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.363100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.01829999999714E-05 |
| Normal-vs-Age(81-100Yrs) |
1.559170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.115800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.910000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.423400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.723050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.077200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.141400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.691900E-02 |
| Normal-VS-Type2 PRCC |
4.33460001225683E-09 |
| Normal-VS-KIRP CIMP |
8.09400000000293E-05 |
| Normal-VS-Unclassified PRCC |
4.583600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.435100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.580300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.867200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.948600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.351700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.532600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.61519997166471E-09 |
| Normal-vs-N1 |
1.184820E-03 |
| Normal-vs-N2 |
5.646400E-04 |
| N0-vs-N1 |
2.441200E-01 |
| N0-vs-N2 |
8.063400E-01 |
| N1-vs-N2 |
4.471800E-01 |
|
|
